Webinars
As the AACR IO 2025 conference approaches, the Scientific Committee has organized several webinars to be held before and after the conference. These free webinars reflect the broad scope of the program and the growing interest in immuno-oncology within the scientific community. Everyone is invited to join these sessions and actively participate in the discussions.
Upcoming events
AI AND MACHINE LEARNING IN IO
June 11, 2025
11:30 a.m.-1 p.m. EST
Virtual
Moderators
- Elana Fertig, University of Maryland, Baltimore, Maryland
- Dana Pe’er, Memorial Sloan Kettering Cancer Center, New York, New York
Panelists
- Arnav Mehta, Massachusetts General Hospital, Boston, Massachusetts
- Benjamin Greenbaum, Memorial Sloan Kettering Cancer Center, New York, New York
- Elham Azizi, Columbia University, New York, New York
This webinar will explore how AI-powered computational modeling, single-cell genomics, and imaging-based profiling are advancing our understanding of the tumor microenvironment, immune escape, immune response prediction, and personalized cancer treatment. Panelists will discuss how genomic repeat elements that mimic viral RNA trigger innate immune responses and how tumors evolve to evade immune detection. By integrating AI with high-throughput sequencing and multi-omics data, experts will share insights into identifying immune vulnerabilities, overcoming resistance mechanisms, and improving precision immunotherapy strategies.
past events
TUMOR MUTATIONAL BURDEN, HETEROGENEITY, AND THE EFFICACY OF IMMUNOTHERAPY
February 4, 2025
View RecordingModerator
Sergio A. Quezada, University College London Cancer Institute, London, United Kingdom
Panelists
- What will it take to realize the success of therapeutic cancer vaccines?
Elizabeth M. Jaffee, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland - Genetic intratumour heterogeneity and cancer immunogenicity
Marco Gerlinger, Queen Mary University of London (QMUL), London, United Kingdom and affiliated with King’s College London, London, United Kingdom - Targeting the microbiome to promote health and end cancer
Jennifer Wargo, University of Texas MD Anderson Cancer Center, Houston, Texas
Join our esteemed panelists as they discuss:
- Impact of mutational heterogeneity on the efficacy of immunotherapy.
- Importance of tumor mutational burden in cancer immunotherapy.
- Clonal heterogeneity and response to immunotherapy.
- Induction of mutagenesis and impact on tumor immunogenicity and treatment efficacy.